Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Als entities : Atea pharmaceuticals, inc. save search
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-02-28 (Crawled : 16:20) - ir.ateapharma.com
AVIR | $3.71 0.0% 270K
|
Health Technology
|
| O: 10.41%
H: 4.57%
C: -7.71%
als financial results report results
Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on February 28, 2022
Published: 2022-02-22 (Crawled : 20:00) - biospace.com/
AVIR | $3.71 0.0% 270K
|
Health Technology
|
| O: -1.01%
H: 4.01%
C: 0.85%
als financial results conference results
Atea Pharmaceuticals Appoints Nancy Gail Berry Agrawal, Ph.D., as Executive Vice President of Preclinical Development
Published: 2022-02-10 (Crawled : 13:30) - biospace.com/
AVIR | $3.71 0.0% 270K
|
Health Technology
|
| O: 2.67%
H: 4.08%
C: -0.84%
als preclinical pre-clinical
Atea Pharmaceuticals to Present at 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-09 (Crawled : 22:00) - globenewswire.com
AVIR | $3.71 0.0% 270K
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
health als thc conference svb leerink global
Atea Pharmaceuticals Announces Publication of Data Supporting Bemnifosbuvir’s (AT-527) Novel Mechanism of Action Against SARS-CoV-2 in Nature Communications
Published: 2022-02-02 (Crawled : 13:00) - biospace.com/
AVIR | $3.71 0.0% 270K
|
Health Technology
|
| O: 2.78%
H: 0.0%
C: 0.0%
at-527 als sars-cov-2 communication communications bemnifosbuvir
Atea Pharmaceuticals Highlights Strategic Priorities for 2022
Published: 2022-01-07 (Crawled : 12:30) - globenewswire.com
AVIR | $3.71 0.0% 270K
|
Health Technology
|
| O: -2.08%
H: 0.0%
C: 0.0%
als
Atea Pharmaceuticals to Present at 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-03 (Crawled : 13:30) - biospace.com/
AVIR | $3.71 0.0% 270K
|
Health Technology
|
| O: 4.03%
H: 0.48%
C: -1.18%
health als thc conference j.p. morgan healthcare conference
Atea Pharmaceuticals Added to the Nasdaq Biotechnology Index
Published: 2021-12-17 (Crawled : 13:30) - biospace.com/
AVIR | $3.71 0.0% 270K
|
Health Technology
|
| O: -2.34%
H: 0.0%
C: 0.0%
als technology nasdaq index biotech iot
Atea Pharmaceuticals Introduces New Strategic Clinical Development Program for AT-527 in COVID-19
Published: 2021-12-14 (Crawled : 23:00) - globenewswire.com
AVIR | $3.71 0.0% 270K
|
Health Technology
|
| O: 1.25%
H: 0.0%
C: -1.48%
at-527 covid-19 als covid
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.